Dr Reddys Laboratories (RDY) Change in Acquisitions & Divestments (2009)
Dr Reddys Laboratories (RDY) posted quarterly Change in Acquisitions & Divestments of $82.0 million for Q4 2009, down 50.3% on a QoQ basis from $165.0 million in Q3 2009.
Dr Reddys Laboratories (RDY) Change in Acquisitions & Divestments (2009) Analysis & Trends
Dr Reddys Laboratories (RDY) has reported Change in Acquisitions & Divestments for 1 consecutive years, with $82.0 million the latest figure, recorded in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.42 Bn | 87.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.63 Bn | 23.57 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.34 Bn | 18.54 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.65 Bn | 12.22 Bn | 785.00 Mn |
| 10 | Dr Reddys Laboratories | 9.82 Bn | 9.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2009 | 82.00 Mn |
| Dec 31, 2009 | 82.00 Mn |
| Sep 30, 2009 | 165.00 Mn |
| Sep 30, 2009 | 165.00 Mn |
| Jun 30, 2009 | 107.00 Mn |
| Jun 30, 2009 | 107.00 Mn |